全文获取类型
收费全文 | 14468篇 |
免费 | 988篇 |
国内免费 | 204篇 |
学科分类
医药卫生 | 15660篇 |
出版年
2024年 | 12篇 |
2023年 | 233篇 |
2022年 | 279篇 |
2021年 | 520篇 |
2020年 | 540篇 |
2019年 | 478篇 |
2018年 | 445篇 |
2017年 | 504篇 |
2016年 | 530篇 |
2015年 | 541篇 |
2014年 | 1085篇 |
2013年 | 1068篇 |
2012年 | 973篇 |
2011年 | 997篇 |
2010年 | 803篇 |
2009年 | 719篇 |
2008年 | 625篇 |
2007年 | 633篇 |
2006年 | 590篇 |
2005年 | 522篇 |
2004年 | 474篇 |
2003年 | 367篇 |
2002年 | 309篇 |
2001年 | 281篇 |
2000年 | 225篇 |
1999年 | 231篇 |
1998年 | 222篇 |
1997年 | 172篇 |
1996年 | 143篇 |
1995年 | 130篇 |
1994年 | 154篇 |
1993年 | 122篇 |
1992年 | 95篇 |
1991年 | 82篇 |
1990年 | 53篇 |
1989年 | 61篇 |
1988年 | 61篇 |
1987年 | 43篇 |
1986年 | 38篇 |
1985年 | 54篇 |
1984年 | 44篇 |
1983年 | 28篇 |
1982年 | 31篇 |
1981年 | 30篇 |
1980年 | 24篇 |
1979年 | 16篇 |
1978年 | 16篇 |
1977年 | 8篇 |
1976年 | 13篇 |
1973年 | 9篇 |
排序方式: 共有10000条查询结果,搜索用时 62 毫秒
31.
目的探讨自制双球囊导管在经皮选择性肝脏隔离灌注化疗(PSIHP)中的应用效果。方法实验猪12头,利用介入放射学方法进行双球囊导管选择性隔离肝脏灌注化疗结合血液灌流。化疗药物选用5-FU。比较灌注及未灌注区域肝细胞形态和凋亡指数。结果灌注区域肝细胞损伤明显,肝细胞凋亡指数(51.82%±5.34%)明显高于未灌注区域肝细胞凋亡指数(4.12%±0.84%)(P<0.01)。结论自制新型双球囊导管能有效隔离肝脏,对未灌注区域肝组织有良好的保护作用,是一种理想的隔离肝脏灌注化疗的球囊导管。 相似文献
32.
骨外科患者拔尿管时注入药物对排尿的影响 总被引:4,自引:0,他引:4
目的探讨提高长时间留置导尿管病人拔管后2h内排尿成功率的方法。方法按入院先后随机将64例导尿的男性骨折病人分两组,单数为观察组,双数为对照组。对照组常规拔尿管,观察组拔尿管时遵医嘱注入地塞米松5mg+2%利多卡因5ml+生理盐水5ml+庆大霉素8万U,比较首次排尿的自觉症状,包括尿痛、排尿困难、排尿障碍等。结果观察组较对照组病人首次排尿出现自觉症状的例数明显减少(P<0.01),有显著性差异。结论拔尿管时注入药物安全有效,明显提高了长期置管病人拔除尿管后首次排尿的成功率,减轻了病人的痛苦,有广泛的应用价值。 相似文献
33.
34.
目的比较静脉麻醉下行胃镜和肠镜检查术病人麻醉管理要点及副反应。方法选择拟行无痛性胃镜、结肠镜检查的患者各120例,在静脉麻醉下行内镜检查。观察其间生命体征变化,比较两组病人对内镜插入的耐受性、副反应以及胃镜和肠镜麻醉管理的侧重点。结果接受胃镜检查的患者麻醉期间生命体征无显著性变化,接受肠镜检查的患者,麻醉期间部分可出现反射性心率减慢和血压下降,需予以对症处理。两组病人对插入胃、肠镜的刺激耐受性良好。结论成功的静脉麻醉虽可达到无痛目的,但应注重对病人呼吸和循环功能监测,确保麻醉安全。 相似文献
35.
Foley尿管气囊压迫治疗骶前静脉丛大出血的评价(附6例报告) 总被引:5,自引:0,他引:5
目的:评价直肠癌根治术中用Foley尿管气囊压迫治疗骶前静脉丛大出血(MPVP)的临床价值。方法:分析1995~2005年用Foley尿管气囊压迫治疗骶前静脉丛大出血6例的临床资料。结果:6例骶前大出血中全部用Foley尿管气囊压迫控制出血,术中出血量为800~1700mL,Foley尿管于术后4d拔除3例,5d1例,6d2例,均无再出血,会阴切口均一期愈合。结论:Foley尿管气囊压迫治疗骶前静脉丛大出血是一种简单安全有效的治疗方法。 相似文献
36.
Péter Móricz Imre Gerlinger Jenő Solt Krisztina Somogyvári József Pytel 《European archives of oto-rhino-laryngology》2007,264(12):1441-1445
Stenosis of the hypopharyngo-oesophageal junction can be a rare complication of laryngectomy and/or partial pharyngectomy
and makes the insertion of voice prosthesis extremely difficult. This study describes the authors’ experiences gained by endoscopic
balloon-catheter dilatation of hypopharyngo-oesophageal stenoses prior to implantation of voice prostheses in four cases.
In two patients a single balloon-catheter dilatation resulted in wide enough pharyngo-oesophageal lumen on the long run. The
average prosthesis wearing-times were 6.8 months in case 1 and 4.6 months in case 2, corresponding to the published literature
data. In case 3, repeated dilatation of the pharyngo-oesophageal transition had proved to be unsuccessful despite taking every
effort with the endoscopic balloon-catheter method. Having excised the stenotic segment, reconstruction with pectoralis major
myocutaneous flap (PMMF) was indicated. Eighteen months later, a repeated restenosis was observed and a free jejunal flap
needed to be performed as a final solution. In case 4, the insertion was carried out into a previously dilated jejunal free
flap, which became gradually ischemic and stenotic since the major head-and neck procedure was carried out that resulted in
prosthesis rejection after just 1 week. The authors emphasize that correct indication of pedicled and free flaps in head and
neck reconstruction is a prerequisite from the aspect of prevention of pharyngo-oesophageal strictures. Endoscopic balloon-catheter
dilatation is a safe and established method for dilatating hypopharyngo-oesophageal stenoses of different origin. The procedure
provides maximum patient benefit with minimal trauma and morbidity; moreover, facilitates insertion of voice prostheses. However,
a single balloon-catheter dilatation cannot always result in wide enough oesophageal lumen on the long run (case 3). Insertion
of a voice prosthesis into a previously dilated ischemic jejunal segment is challenging and avoidable due to risks of complications. 相似文献
37.
Toshio Imanishi Mikio Arita Yoshiaki Tomobuchi Masanori Hamada Takuzo Hano Ichiro Nishio 《Clinical and experimental pharmacology & physiology》1997,24(11):800-806
1. This study was undertaken to evaluate the preventive effects of locally administered argatroban, a competitive inhibitor of thrombin-induced platelet activation, on restenosis after balloon angioplasty. 2. A hydrogel-coated balloon catheter was immersed three times in argatroban/saline solution (1 mg/mL) for 60 s, inflated to a pressure of 606 kPa and left in the rabbit common carotid artery for 1 min. The same procedure was performed, without drug, as a control. The pharmacokinetics of delivered argatroban in the arterial wall were assessed using [14C]-argatroban. Platelet deposition 2h after balloon injury was quantified by fluorescence studies using antiplatelet antibody. Vascular smooth muscle cell (VSMC) proliferation 3 days after balloon injury was assessed by immunohistochemical staining for proliferative cell nuclear antigen (PCNA). In a clinical study, we divided 50 elective patients into two groups: argatroban and control. 3. In the experimental study, the mean quantities of argatroban at 0, 2 and 6 h after deflation wer. 24.63, 0.49 and 0.11 nmol/g wet weight of artery, respectively. Argatroban was undetected 24 h after deflation. Two hours after deflation, argatroban-treated arteries showed less platelet adhesion than saline-treated controls. The mean number of PCNA-positive cells was 16.9 and 43.8% in the argatroban and control groups, respectively (P < 0.01). In the clinical study, the mean late gain loss was 8.2 and 27.3% in the argatroban and control groups, respectively (P < 0.05). The mean late restenosis rate was 11.1 and 41.4% in the argatroban and control groups, respectively (P<0.05). 4. These data suggest that blood coagulation plays a significant role in VSMC proliferation after balloon injury and that locally administered argatroban using hydrogel-coated balloon catheter may prevent post-percutaneous transluminal coronary angioplast. restenosis. 相似文献
38.
HANS KOTTKAMP M.D. GERHARD HINDRICKS M.D. MARTIN BORGGREFE M.D. GÜNTER BREITHARDT M.D. 《Journal of cardiovascular electrophysiology》1997,8(4):451-468
Catheter Ablation Techniques in AVNRT. Radiofrequency catheter ablation has been established as a first-line curative treatment modality in patients with symptomatic AV nodal reentrant tachycardia (AVNRT). The successful sites of stepwise catheter ablation approaches of the so-called fast and slow pathways strongly suggest that AVNRT involves the atrial approaches to the AV node. The typical fast pathway ablation sites are located anterosuperior toward the apex of the triangle of Koch, which also contains the compact AV node, whereas the usual slow pathway ablation sites are located posteroinferior toward the base of the triangle of Koch at a greater distance to the compact AV node and bundle of His. Accordingly, ablation studies with large patient cohorts have demonstrated that fast pathway ablation carries a higher risk of inadvertent complete AV block. Thus, the slow pathway is clearly the primary target site, and fast pathway ablation is rarely necessary. Different approaches for slow pathway ablation have been elaborated: anatomically oriented stepwise techniques, ablation guided by double potentials recorded within the area of the slow pathway insertion, and combined techniques. The modern concept of AVNRT suggests that this arrhythmia involves the highly complex three-dimensional nonuniform anisotropic AV junctional area. Accordingly, mapping and ablation studies demonstrated that the anterior approach is not identical with fast pathway ablation, and the posterior approach is not identical with slow pathway ablation. Therefore, it is essential for interventional electrophysiologists to familiarize themsdves with the anatomic and electrophysiologic details of this complex and variable specialized AV junctional region. In this review, the anatomic and pathophysiologic aspects of the AV junctional area as they relate to interventional therapy are summarized briefly, and the catheter techniques for ablation of the so-called fast and slow AV nodal pathways for the treatment of AVNRT are described. 相似文献
39.
Infectious peritonitis complicating suprapubic catheter removal 总被引:1,自引:0,他引:1
Dr M. Heit 《International urogynecology journal》1997,8(1):47-49
Peritonitis following suprapubic catheter placement may result from inadvertent placement of the drain through the large and small bowel and bladder base. The author describes a case of infectious peritonitis which developed after suprapubic catheter removal. The patient, underwent suprapubic catheter placement after Burch Colposuspension for genuine stress incontinence. The catheter was removed with a full bladder after an uneventful postoperative course, but the patient subsequently developed acute infectious peritonitis due to extravasated urine from the cystostomy site. It was concluded that suprapubic catheters should be removed after the bladder is emptied, to prevent this complication. This may be most important in patients who void without residual prior to epithelialization of the cystostomy site.Editorial Comment: This paper illustrates another complication of suprapubic catheter use. In this case peritonitis developed secondary to infected urine entering the peritoneal cavity after removal of the catheter when the bladder was full. The peritoneum had not been closed at the time of the original Burch procedure. The authors make the point of planning removal when the bladder is empty. Another consideration would be to close the peritoneum when a suprapubic catheter is used. 相似文献
40.
静脉用丙种球蛋白治疗新生儿重症感染对细胞免疫功能的影响 总被引:1,自引:0,他引:1
应用静脉注丙球(IVIG),配合抗生素(An)治疗重症感染新生儿12例,在观察疗效及不良反应的同时,通过检测患儿治疗前后T细胞亚群及白细胞介素Ⅱ(IL-2)产生水平的变化,观察IVIG对细胞免疫功能的影响。结果显示:患儿CD_3~+、CD_4~+、CD_8~+细胞及IL-2产生水平均明显低于正常同龄新生儿。经IVIG+An及单用An治疗后,T细胞各亚群及IL-2水平均明显增高。IVIG组与An组比较,诒疗后IVIG组CD_4~+细胞明显高于An组,IL-2水平也较An组为高,但无统计学意义。疗效观察,中毒症状及原发病体征好转消失时间IVIG组较An组明显缩短。本文还就IVIG对细胞免疫功能影响的可能机制进行了讨论。 相似文献